Physician profile
Martha C Storrie
NPI 1376608265
$1,029.14
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $82.43 · 2021: $292 · 2022: $376 · 2023: $85.63 · 2024: $29.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $250.37 | 2020-2023 | Tlando, Xyosted, Nocdurna |
| Astellas Pharma US INC | $233.11 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $131.05 | 2021-2024 | |
| Medtronic USA, INC. | $97.32 | 2019 | |
| Coloplast Corp | $71.27 | 2021-2023 | Speedicath |
| Merck Sharp & Dohme LLC | $62.60 | 2022 | |
| Pfizer INC. | $53.20 | 2021-2022 | |
| Janssen Biotech, INC. | $46.12 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $21.49 | 2022 | |
| Dendreon Pharmaceuticals LLC | $18.35 | 2021 | |
| Blue Earth Diagnostics | $16.11 | 2021 | |
| Acerus Pharmaceuticals Corporation | $15.37 | 2020 | |
| Boston Scientific Corporation | $12.78 | 2023 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Storrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.